View Older Stories View More Recent Stories

May 11, 2026 04:31PM Erasca, Inc. (ERAS) Misses Q1 EPS by 49c
May 1, 2026 04:08PM SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton
Apr 29, 2026 12:22PM Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses
Apr 28, 2026 01:54PM Erasca shares cut in half after patient death in clinical trial
Apr 28, 2026 10:49AM Increasing unusual option volume: ERAS SANM OGN BBBY SNBR PAGS CDNS PII
Apr 28, 2026 06:42AM H.C. Wainwright Reiterates Buy Rating on Erasca Inc (ERAS)
Apr 28, 2026 05:14AM Erasca Inc (ERAS) PT Raised to $9 at BofA Securities
Apr 27, 2026 04:49PM Erasca, Inc (ERAS) releases slides on phase 1 data for RAS cancer drug ERAS-0015
Apr 27, 2026 07:24AM Erasca Inc (ERAS) PT Raised to $30 at Stifel After CEO Chat
Apr 20, 2026 11:06AM Jefferies stays Buy on Erasca Inc (ERAS): ASCO'26 a potential inflection point with Ph1 monotx data presentation likely
Apr 13, 2026 12:00PM Jefferies on Erasca Inc (ERAS): RVMD data leaves bar for ERAS 'unchanged'
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?
Mar 13, 2026 07:47AM Erasca (ERAS) Reiterated at Buy by Stifel After Q4 Results
Mar 13, 2026 06:43AM Erasca Inc (ERAS) PT Raised to $20 at H.C. Wainwright
Mar 10, 2026 03:09PM Erasca, Inc (ERAS) 3500 contracts of December 15 calls trade
Mar 10, 2026 02:36PM Erasca Inc (ERAS) PT Raised to $20 at Stifel
Mar 10, 2026 08:03AM Erasca expands ERAS-0015 license to secure worldwide rights
Mar 5, 2026 05:16PM Erasca Inc (ERAS) PT Raised to $20 at Clear Street
Feb 9, 2026 07:29AM Erasca (ERAS) Reiterated at Buy by Stifel: Chinese 'me too Assets' Unlikely
Jan 27, 2026 07:11AM Erasca Inc (ERAS) PT Raised to $12 at Guggenheim
Jan 27, 2026 01:06AM Mizuho Assumes Erasca Inc (ERAS) at Outperform
Jan 26, 2026 06:47AM Erasca Inc (ERAS) PT Raised to $15 at H.C. Wainwright
Jan 13, 2026 06:40AM Erasca Inc (ERAS) PT Raised to $11 at H.C. Wainwright
Jan 12, 2026 12:12PM Erasca Inc (ERAS) PT Raised to $10 at Stifel
Jan 12, 2026 08:03AM Erasca reports early clinical responses for cancer drug ERAS-0015
Jan 7, 2026 12:28PM Oppenheimer on BridgeBio Oncology Therapeutics, In (BBOT): 'We think the lack of idiosyncratic toxicity is particularly notable for BBO-10203'
Jan 7, 2026 12:11PM Erasca, Inc (ERAS) Pulls Back from 20+pct Jump, Stifel: 'Today's Strength Driven by Competitor Readthrough'
Jan 7, 2026 03:45AM Piper Sandler Starts Erasca Inc (ERAS) at Overweight
Dec 9, 2025 07:18AM Erasca Inc (ERAS) PT Raised to $5 at Mizuho
Nov 14, 2025 06:33AM Erasca Inc (ERAS) PT Raised to $5 at Guggenheim
Nov 13, 2025 09:39AM Stifel Reiterates Buy Rating on Erasca Inc (ERAS) Following Q3 Results
Nov 6, 2025 08:06AM Erasca receives US patent for pan-RAS molecular glue ERAS-0015
Oct 15, 2025 04:09PM Stifel Starts Erasca Inc (ERAS) at Buy
Sep 3, 2025 06:10AM BofA Securities Double Downgrades Erasca Inc (ERAS) to Underperform
Aug 18, 2025 03:38AM Morgan Stanley Downgrades Erasca Inc (ERAS) to Equalweight
Aug 12, 2025 05:59PM Erasca, Inc. (ERAS) Reports In-Line Q2 EPS
Aug 12, 2025 04:49PM Erasca, Inc (ERAS) Files $500M Mixed Shelf
Jun 2, 2025 08:06AM Erasca, Inc (ERAS) Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001
May 13, 2025 04:07PM Erasca, Inc. (ERAS) Tops Q1 EPS by 2c
May 13, 2025 08:04AM Erasca, Inc (ERAS) Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway
Mar 26, 2025 06:01AM Raymond James Starts Erasca Inc (ERAS) at Outperform, PT $5
Mar 20, 2025 04:03PM Erasca, Inc. (ERAS) Tops Q4 EPS by 2c
Dec 12, 2024 01:16PM Clear Street Starts Erasca Inc (ERAS) at Buy
Nov 18, 2024 03:21AM Jefferies Starts Erasca Inc (ERAS) at Buy
Nov 12, 2024 04:04PM Erasca, Inc. (ERAS) Tops Q3 EPS by 6c
Oct 25, 2024 05:44AM Erasca Inc (ERAS) PT Raised to $3.50 at Goldman Sachs
Oct 24, 2024 08:02AM Erasca, Inc (ERAS) Announces Strong Momentum for Naporafenib and RAS Targeting Franchise
Aug 13, 2024 01:52PM Erasca Inc (ERAS) PT Lowered to $3 at Goldman Sachs
Aug 13, 2024 06:11AM Erasca Inc (ERAS) PT Raised to $6 at H.C. Wainwright
Aug 12, 2024 04:03PM Erasca, Inc. (ERAS) Misses Q2 EPS by 11c
View More Recent Stories View Older Stories